Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,690 | 56,561 | 73,820 | 65,243 | 28,840 |
| TOTAL | $45,054 | $59,055 | $76,480 | $66,840 | $30,337 |
| Non-Current Assets | |||||
| PPE Net | 142 | 134 | N/A | 0 | 5 |
| Other Non-Current Assets | 162 | 201 | 528 | 358 | 548 |
| TOTAL | $304 | $335 | $528 | $358 | $553 |
| Total Assets | $45,359 | $59,390 | $77,008 | $67,198 | $30,890 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,685 | 6,983 | 1,219 | 1,309 | 1,415 |
| Accrued Expenses | 2,841 | 2,425 | 8,314 | 2,188 | 1,735 |
| TOTAL | $17,087 | $13,630 | $9,821 | $3,756 | $3,271 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,205 | 19,506 | 23,021 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 231 | 490 |
| TOTAL | $9,267 | $19,629 | $23,185 | $231 | $490 |
| Total Liabilities | $26,354 | $33,259 | $33,006 | $3,988 | $3,761 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,396 | 36,679 | 30,724 | 28,449 | 22,262 |
| Common Shares | 13 | 11 | 10 | 9 | 7 |
| Retained earnings | -182,111 | -144,501 | -101,558 | -60,704 | -43,785 |
| TOTAL | $19,005 | $26,131 | $44,002 | $63,210 | $27,130 |
| Total Liabilities And Equity | $45,359 | $59,390 | $77,008 | $67,198 | $30,890 |